Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05687292 · ClinicalTrials.gov registry record

Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children

A clinical trial of Congenital Heart Disease, sponsored by Boston Children's Hospital.

Active
Registry status
330
Enrollment target
1
Study location

NCT05687292: Active study of Congenital Heart Disease, sponsored by Boston Children's Hospital.

NCT05687292 is a study of Congenital Heart Disease that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 330 participants, below the 469-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05687292, a study of Congenital Heart Disease, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
330 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the impact of a clinical decision support system (CDSS) in children receiving mechanical ventilation (MV) after surgery for congenital heart disease (CHD). The main question it aims to answer is: -What is the impact of a CDSS designed to facilitate weaning and discontinuation of MV on the duration of MV in post-operative congenital cardiac surgery patients? Participants will be identified as eligible to initiate weaning from mechanical ventilation. Providers will decide whether or not to initiate weaning based on recommendations provided by the CDSS. Researchers will compare patients exposed to the CDSS with a historical cohort to see if the CDSS facilitated a decrease in MV duration.

Primary Outcome

Measured in days; Obtained from date/time of initial extubation minus date/time of admission from surgery, divided by 24 to give an exact determination of days

Conditions Studied

Interventions

  • DEVICE Clinical decision support system (CDSS) for ventilator weaning

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2024-11-18
Est. Completion 2027-03-01
Boston Children's Hospital

462 total trials

What the registry record for NCT05687292 still lists

NCT05687292 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 469-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (30% lower).

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Clinical decision support system (CDSS) for ventilator weaning is the first listed.

NCT05687292 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05687292 about?

NCT05687292 is a clinical study titled "Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children". The goal of this study is to evaluate the impact of a clinical decision support system (CDSS) in children receiving mechanical ventilation (MV) after surgery for congenital heart disease (CHD). The main question it aims to answer is: -What is the impact of a CDSS designed to facilitate weaning and ...

What is the current status of trial NCT05687292?

This trial is currently active not recruiting. The enrollment target is 330 participants. The study started on 2024-11-18. Estimated completion is 2027-03-01.

What conditions does trial NCT05687292 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

What interventions are being tested in trial NCT05687292?

The interventions under investigation include: Clinical decision support system (CDSS) for ventilator weaning (DEVICE).

Who is sponsoring clinical trial NCT05687292?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05687292 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05687292's enrollment target sits among peer trials

330 10th of 63 higher than 54 of 63 other Congenital Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  • NCT03932773 · 330 participants · NA

    Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05687292, the US trial registry maintained by the National Library of Medicine. NCT05687292 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.